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Purpose. To investigate the heterogeneous enhancement pattern in normal lymph nodes of healthy mice by dierent albumin-
binding contrast agents.Methods. e enhancement of normal lymph nodes was assessed in mice by dynamic contrast-enhanced
MRI (DCE-MRI) after the administration of two contrast agents characterized by dierent albumin-binding properties:
gadopentetate dimeglumine (Gd-DTPA) and gadobenate dimeglumine (Gd-BOPTA). To take into account potential hetero-
geneities of the contrast uptake in the lymph nodes, k-means cluster analysis was performed on DCE-MRI data. Cluster spatial
distribution was visually assessed. Statistical comparison among clusters and contrast agents was performed on semiquantitative
parameters (AUC, wash-in rate, and wash-out rate) and on the relative size of the segmented clusters. Results. Cluster analysis of
DCE-MRI data revealed at least two main clusters, localized in the outer portion and in the inner portion of each lymph node.
With both contrast agents, AUC (p< 0.01) and wash-in (p< 0.05) rates were greater in the inner cluster, which also showed a
steeper wash-out rate than the outer cluster (Gd-BOPTA, p< 0.01; Gd-DTPA, p  0.056).e size of the outer cluster was greater
than that of the inner cluster by Gd-DTPA (p< 0.05) and Gd-BOPTA (p< 0.01). e enhancement pattern of Gd-DTPA was not
signicantly dierent from the enhancement pattern of Gd-BOPTA. Conclusion. DCE-MRI in normal lymph nodes shows a
characteristic heterogeneous pattern, discriminating the periphery and the central portion of the lymph nodes. Such a pattern
deserves to be investigated as a diagnostic marker for lymph node staging.
1. Introduction
Dynamic contrast-enhanced MRI (DCE-MRI) has been
widely used to quantify tissue perfusion in preclinical [1, 2]
and clinical studies. In DCE-MRI, multiple T1-weighted
images are acquired before and at dierent time points
after the administration of a Gd-based contrast agent,
allowing the quantication of parameters related to perfu-
sion [1, 2]. e diagnostic usefulness of DCE-MRI in tumors
largely relies on the peculiar features of the tumor tissue:
increased blood volume fraction and vessel permeability.
anks to high-resolution T1-weighted images, DCE-
MRI has been extensively applied in clinical studies to
characterize the breast [3] and solitary pulmonary nodules [4]
and in general in cancer diagnosis including the prostate [5]
and liver [6]. Moreover, DCE-MRI can have a role for the
detection and characterization of lymph nodes. Quantitative
or semiquantitative parameters extracted from DCE-MRI
data (describing, for example, the uptake and wash-out of
the contrast agent) are expected to discriminate between
positive and negative nodes. Accordingly, DCE-MRI showed
promising performance to assess suspicious lymph nodes at
dierent sites, such as the head and neck [7–9], rectal [10, 11],
and cervical [12–14] and in the axillary lymph nodes in breast
cancer patients [15–19], for which the role of MRI, including
DCE-MRI, was recently reviewed [20].
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.e overarching aim of our study is to deﬁne the di-
agnostic potential of DCE-MRI for lymph node staging. For
this purpose, the ﬁrst step is investigation of normal lymph
nodes since the deﬁnition of the enhancement pattern of
normal nodal tissue is a needed preparatory knowledge to
reliably detect alterations induced by metastasization. .e
aim of the present study is therefore obtaining the deﬁnition
of the enhancement pattern in DCE-MRI of normal lymph
nodes through systematic investigation in healthy mice. A
further aim is to develop a semiautomatic and operator-
independent image analysis procedure by using cluster
analysis of DCE-MRI enhancement patterns.
Moreover, Gd-based contrast agents can have diﬀerent
binding properties to albumin and consequently diﬀerent
capability to reveal blood vessels [21, 22], potentially gen-
erating a diﬀerent lymphatic uptake/drainage pattern. In
order to investigate if and how diﬀerent protein binding may
aﬀect DCE-MRI ﬁndings in normal lymph nodes, two Gd-
based contrast agents were administered, namely (i) gado-
pentetate dimeglumine (Gd-DTPA) and (ii) gadobenate
dimeglumine (Gd-BOPTA). Speciﬁcally, Gd-BOPTA can be
classiﬁed as an albumin-bound contrast agent [23], while
Gd-DTPA is a non-albumin-bound extracellular contrast
agent.
2. Methods
2.1.MRI Acquisition. Athymic nude mice were anesthetized
by inhalation of a mixture of N2 and O2 containing 0.5–1%
isoﬂurane (Forane, Abbott) and were cannulated in the tail
vein for contrast agent injection during DCE-MRI scan. A
single birdcage coil (3.5 cm i.d.) conﬁguration was used for
radiofrequency excitation and MRI signal detection. Images
were acquired using a BioSpec tomograph (Bruker, Karls-
ruhe, Germany) equipped with a 4.7 T, 33 cm bore hori-
zontal magnet (Oxford Ltd., Oxford, United Kingdom). For
the imaging session, mice were placed in a prone position
over a heated bed; body temperature and respiratory rate
were monitored by using an MRI-compatible physiological
monitor (PC-SAM, Small Animal Instruments, Inc., NY).
Before the administration of the contrast agent, a
standard non-fat-suppressed T1-weighted sequence (mul-
tislice RARE with TR/TE: 550/7.6ms, ﬂip angle: 180°, matrix
size: 175×100, number of slices: 6, ﬁeld-of-view:
3.5× 2.0mm2, slice thickness: 0.5mm, number of aver-
ages: 8, and RARE factor: 8) was applied to investigate the
presence of a fatty hilum, which has been often reported in
human lymph nodes [24, 25].
Afterwards, a dynamic series of multislice T1-weighted
RARE images were acquired with fat suppression and with
the following parameters: TR/TE: 550/7.6ms, ﬂip angle:
180°, matrix size: 175×100, number of slices: 6, ﬁeld-of-view:
3.5× 2.0mm2, slice thickness: 0.5mm, number of averages:
8, RARE factor: 8, number of scans: 70, and total acquisi-
tion time: approximately 46minutes. TwoGd-based contrast
agents were tested in diﬀerent sessions, by bolus injection
(100 µmol/kg) during the time interval between the third
and fourth scan of the dynamic series: (i) Gd-DTPA and
(ii) Gd-BOPTA.
DCE-MRI was performed in total on 9 healthy mice (5
mice were injected by Gd-DTPA and 4 by Gd-BOPTA).
.e experimental plan received authorization from the
Italian Ministry of Health (approval number: 676/2018-PR)
and was approved by the Animal Care and Use Committee
of the University of Verona. Animal work was conducted
following the Italian law (D.L. no. 26 of 4 March 2014) and
the European Union normative (2010/63/EU). Major eﬀorts
were performed to minimize the number of animals and to
avoid their suﬀering.
2.2. Image Analysis. Some DCE-MRI scans were aﬀected by
peristalsis and breath-induced motion. To compensate for
these displacements, a linear registration approach was
adopted by means of the MCFLIRT tool of FSL [26]. Even
though that tool is designed for brain imaging, it proved to
be eﬀective even in the abdominal region. .e 2nd volume
after the contrast agent injection was used as a reference
image for the registration of the whole time series. When the
linear registration approach was not suﬃcient, a nonlinear
approach was adopted, carrying out nonlinear registration
by the FNIRT tool of FLS and ﬁnely tuning the registration
parameters to obtain a “gentle” warp ﬁeld.
.e subsequent postprocessing was performed by
MATLAB (MathWorks®, Natick, MA). For each node,normalized diﬀerential enhancement (NDE) curves were
calculated on a pixel-by-pixel basis, subtracting the signal
intensity before contrast injection (SIPRE) from the signal
intensity at a given time point SI(t) and normalizing it by
(DEMAX)MUSCLE, that is, the maximal diﬀerential en-
hancement over an area drawn on the tight muscle:
NDE(t) �
SI(t)− SIPRE[ ]
DEMAX( )MUSCLE
. (1)
NDE was normalized by the signal intensity of the
muscle to compensate, at least partially, any possible dif-
ference in the eﬀectively administered dosage of the contrast
agents.
For each lymph node, the central slice was identiﬁed and
a ROI was manually drawn to cover the entire nodal tissue.
To investigate the enhancement pattern in the nodes,
cluster analysis was performed pixel by pixel on the NDE
curves by means of a k-means algorithm. .is algorithm
requires as an input the number of clusters to be identiﬁed,
and the minimum value (two clusters) was chosen to detect
potential heterogeneities. To verify whether this arbitrary
choice could be appropriate, principal component analysis
(PCA) was performed on the same set of NDE curves, to
obtain the data variance explanation as a function of the
number of components.
Segmented colour-coded maps were obtained for each
lymph node, to visualize the spatial distribution of each
cluster obtained by cluster analysis.
After cluster analysis, in each lymph node, the NDE
curves of each pixel belonging to a speciﬁc cluster were
averaged to obtain the cluster-averaged NDE curves.
Semiquantitative parameters were then extracted from these
curves, namely, area under the curve (AUC), wash-in rate,
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and wash-out rate. .e wash-in rate was deﬁned as the
maximum slope of the NDE curve between two consecutive
time points comprised between the last baseline point and
the point of maximal enhancement [27]. .e wash-out rate
was deﬁned as the slope of the line that best ﬁts the last 40
time points (i.e., scans 31 – 70) of the enhancement curve
[21]. Both wash-out and wash-in rates were normalized by
the maximal enhancement in each lymph node.
Statistical diﬀerences in the semiquantitative curve pa-
rameters (between clusters and between contrast agents)
were assessed by two-way ANOVA, and the results were
corrected for multiple comparisons with the Bonferroni
method.
2.3. Histological Analysis. For histological investigation,
lymph nodes were excised and ﬁxed in 4% para-
formaldehyde for four hours. After ﬁxation and embedding
in paraﬃn, 7 μm thick sections were cut and stained with
hematoxylin and eosin (H&E). .e sections were observed
using an optical microscope (Olympus BX63; Life Science
Solutions, Centre Valley, PA) at 4x and 10x magniﬁcations.
3. Results
Only superﬁcial inguinal lymph nodes, clearly visible on
DCE-MRI, were considered. Due to motion induced by
breathing and bowel peristalsis during the MRI acquisition,
the registration procedure was applied in 9 nodes. In 2 cases,
the linear registration approach was not suﬃcient, being the
images aﬀected by bowel motion really close to the node, and
they required nonlinear correction. In one case, motion
produced a very large shift that was not fully recovered by
the motion correction procedure, and the lymph node was
excluded from the successive analysis. In total, 15 nodes were
successfully identiﬁed and included in the analysis (9 by Gd-
DTPA and 6 by Gd-BOPTA). Representative fat-suppressed
DCE-MRI images of a healthy node are reported in
Figures 1(a)–1(c), with the corresponding standard T1-
weighted images (Figures 1(d)–1(f )). .e node indicated
by the green arrow was the one excluded from the analysis
because of a clear displacement of its position during the
scan session. Of note, within our spatial resolution, none of
the observed lymph nodes showed a fatty hilum, as exem-
plarily shown in Figures 1(d)–1(f ).
Cluster analysis revealed a heterogeneous structure in
the enhancement pattern of the lymph nodes. PCA per-
formed on the NDE curves demonstrated that two main
components were necessary and suﬃcient to explain at least
90% of the variance in all the 15 nodes (Figure 2). Additional
components negligibly increased variance explanation.
Consequently, the successive k-means clustering was per-
formed by using two clusters. Of relevance, these two
clusters were localized in the outer portion and in the inner
portion of each lymph node in most of the investigated
nodes..e spatial distribution and diﬀerent enhancement of
the identiﬁed clusters are shown in Figure 3, for a repre-
sentative lymph node, with the corresponding description of
the segmentation performed by k-means clustering. .e
curves clearly show diﬀerent shapes, with the inner cluster
being characterized by greater contrast uptake with respect
to the outer cluster (Figure 3(d)).
(a) (b) (c)
(d) (e) (f )
Figure 1: Precontrast (a), early (b), and late (c) enhancement of DCE-MRI images acquired, respectively, before 80 and 800 seconds after the
administration of Gd-BOPTA and after a motion correction procedure. .e lymph nodes are indicated by red arrows. Unsaturated fat T1-
weighted images (same slice as (a)–(c)) before (d) and about 50minutes after (e) the administration of the contrast agent, i.e., after the
acquisition of the DCE-MRI scan; (f ) is the same as (e) after a nonlinear motion correction procedure. Green arrows indicate a large
displacement of the left node from (d) to (e) that was not fully recovered in (f) and consequently was excluded from the successive analysis.
Frames (d)–(f ) also show that a fatty hilum is not present. .e white strip indicated by the violet arrow is a vial ﬁlled by gadolinium solution
used as a standard signal in all DCE-MRI sequences.
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e cluster-averaged NDE curves and the corresponding
coloured segmented maps of all the 15 examined lymph
nodes are shown in Figure 4, conrming the peculiar het-
erogeneous enhancement pattern.
e parameters calculated on the cluster-averaged NDE
curves are reported in Table 1, and the corresponding mean
values are shown in Figure 5.
Two-way ANOVA was applied to compare the semi-
quantitative perfusion parameters averaged over the two
clusters (signicant dierences are reported in Figure 5). As
apparent from Figure 5, AUCs and wash-in rates were sig-
nicantly smaller in the outer cluster, regardless of the ad-
ministered contrast agent. e size of the outer cluster was
signicantly greater than the size of the inner cluster with
either Gd-DTPA or Gd-BOPTA. e wash-out rates were
signicantly dierent between the two clusters with Gd-
BOPTA, but close to be signicant (p  0.056) with Gd-
DTPA.
Two-way ANOVA performed through contrast agents
revealed no statistically signicant dierences in the en-
hancement pattern of the two contrast agents tested here.
Histological analysis performed with H&E staining
conrmed a heterogeneous structure of the normal node
(Figures 6(a) and 6(b) (at 4x and 10x magnication)). e
cortex (highlighted with blue dotted line in Figure 6) and the
medulla of the node are clearly distinguishable.
4. Discussion
In this study, cluster analysis was applied on DCE-MRI data
acquired on normal nodes of healthy mice by two Gd-based
contrast agents characterized by dierent albumin-binding
properties. k-Means clustering was applied to identify po-
tential heterogeneities, and the minimum number of clusters
was utilized in the algorithm. Of note, PCA suggested that
most of the variability of the lymph node contrast enhance-
ment could be accounted for by two main components with
both contrast agents.e applied clustering method was based
only on the enhancement pattern and not on the spatial
position of each pixel assigned to the cluster; that is, neigh-
borhood connectivity was not considered by the algorithm.
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Figure 2: Principal component analysis (PCA) demonstrates that two principal components are su¨cient to explain at least 90% of the
variance in all the 15 nodes. Additional components negligibly increase variance explanation. e percentage of variance is reported in
ordinate, and the component number (equal to the number of dynamic scans) is reported in abscissa. e whole range and a detailed range
(in the inset) are shown.
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Of relevance, such a heterogeneous enhancement pat-
tern arising from k-means evidenced a marked anatomical
structure, regardless of the contrast agent used. In fact, the
two clusters identied in each node resulted clearly localized
in the outer portion and in the inner portion of the nodes,
respectively. e observed pattern seems to be compatible
with the functional organization of a normal lymph node,
composed of two main functional units, the cortex and the
medulla. Since the lymphatic ªow is directed from the
capsule and the cortex of the lymph node towards the
medulla and the hilum, in this latter portion the contrast
agents might accumulate also because of interstitial diu-
sion, at least partially explaining the greater contrast uptake
in the inner region of the lymph nodes.
e observed spatial pattern characterized the heteroge-
neous distribution of the enhancement in all the assessed
lymph nodes. Independently from the contrast agent used,
AUC and wash-in rate were greater in the inner cluster, which
also showed a steeper wash-out rate than the outer cluster
both with Gd-BOPTA and by Gd-DTPA. On the contrary, the
enhancement of Gd-DTPA was not signicantly dierent
from the enhancement pattern of Gd-BOPTA.
Many studies investigated the role of postcontrast T1
imaging in assessing the lymph node status, including
quantitative assessment on DCE-MRI, but to our
knowledge, the peculiar heterogeneity of contrast en-
hancement in normal nodes has not been reported before.
To the best of our knowledge, only one study focused on
normal nodes, analysing axillary lymph nodes in breast
cancer patients [28]. However, that study focused on the
enhancement curve of a single region of interest placed
inside the cortex of the healthy nodes without covering the
hilum to assess potential heterogeneity. As shown in native
precontrast T1-weighted images, in our study, none of the
assessed mice nodes showed a fatty hilum, allowing to
include the whole nodes in the analysis of the contrast
enhancement heterogeneity and the subsequent segmen-
tation procedure.
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Figure 3: Precontrast (a), early (b), and late (c) DCE-MRI images (the same slice reported in Figures 1(a)–1(c) is shown) of a representative
lymph node (#15). e region of interest (in yellow in (a)–(c)) was manually drawn to encompass the whole lymph node. e long-axis size
of this lymph node was around 2.5mm. k-means clustering assigned each pixel-based NDE curve (thin dashed lines) to one of the two
clusters (d); cluster-averaged NDE curves are also shown (thick black continuous lines). e obtained segmentation map is shown with the
corresponding colours (e).
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Interestingly, in a study aiming at classifying axillary
lymph nodes in breast cancer patients [18], the best per-
forming feature was a morphological feature described as the
degree to which the enhancement structure extends in a
radial pattern originating from the centre of the node lesion.
In our study, which of course needs to be conrmed on
human subjects, an intrinsic radial structure on normal
nodes was revealed, and it is reasonable to speculate that
such a structure might be altered in metastatic nodes.
It is worth noting that the identication of a normal
enhancement pattern might have a role in the detection of
possible alterations induced by the metastatic transformation.
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Figure 4: Enhancement pattern-based k-means clustering on 15 healthy nodes with Gd-DTPA (nodes #1–9) and with Gd-BOPTA (nodes
#10–15). e red/green colours used to report the cluster-averaged NDE curves correspond to the colour used to localize them in the
corresponding segmentation maps (on the right of each plot).
Table 1: Semiquantitative parameters on segmented clusters.
Node
AUC (a.u.) Wash-in (a.u./min) Wash-out (a.u./min) Volume (%)
Inner Outer Inner Outer Inner Outer Inner Outer
Gd-DTPA
#1 217± 41 100± 25 1.3± 0.3 0.8± 0.3 −3.8± 0.8 −1.5± 0.6 25 75
#2 124± 16 71± 12 1.9± 0.3 1.2± 0.5 −3.0± 0.5 −1.6± 0.4 19 81
#3 101± 14 58± 13 2.6± 0.4 1.2± 0.3 −1.9± 0.2 −1.2± 0.3 21 79
#4 143± 23 74± 17 1.6± 0.5 0.9± 0.4 −0.6± 0.6 −0.5± 0.4 26 74
#5 100± 9 69± 9 1.1± 0.7 1.1± 0.4 −0.7± 0.3 −0.4± 0.3 49 51
#6 91± 9 63± 6 1.7± 0.5 1.2± 0.5 −0.5± 0.3 −0.3± 0.2 32 68
#7 98± 11 66± 9 1.4± 0.4 1.2± 0.5 −0.7± 0.4 −0.4± 0.2 33 67
#8 178± 26 99± 22 1.1± 0.3 1.0± 0.3 −1.1± 0.6 −0.5± 0.4 29 71
#9 149± 27 91± 18 1.5± 0.5 1.0± 0.5 −0.4± 0.7 −0.6± 0.3 25 75
Gd-BOPTA
#10 211± 33 109± 29 1.4± 0.3 1.2± 0.2 −2.7± 0.5 −1.2± 0.4 47 53
#11 157± 23 97± 14 2.3± 0.4 1.3± 0.4 −2.2± 0.6 −1.2± 0.3 14 86
#12 88± 14 51± 12 1.3± 0.3 1.0± 0.3 −2.3± 1.2 −1.2± 0.7 40 60
#13 51± 9 29± 7 1.9± 0.4 1.3± 0.4 −2.1± 0.4 −1.3± 0.3 38 62
#14 61± 7 36± 8 1.5± 0.5 1.3± 0.7 −1.4± 0.2 −0.9± 0.3 43 57
#15 109± 18 48± 16 1.7± 0.3 1.1± 0.4 −3.5± 0.8 −1.3± 0.5 29 71
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For example, the accuracy obtained by lymphotropic iron
oxide nanoparticles for nodal staging [29, 30] was based on
the negative enhancement observed in normal nodes, which
was modied by the presence of a metastatic lesion in the
nodes. Similarly, in gadofosveset-enhanced MRI, the aspect
of the chemical shift artefact encircling the lymph nodes
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Figure 5: Mean parameter values calculated averaging on the lymph nodes evaluated with the same contrast agent. Statistical signicance
levels obtained comparing by two-way ANOVA the two segmented clusters are also shown (∗∗p< 0.01 and ∗p< 0.05). (a) Volume (%).
(b) AUC (a.u.). (c) Wash-in rate (a.u./min). (d) Wash-out rate (a.u./min).
(a) (b)
Figure 6: H&E staining of normal lymph nodes. (a) e lymphatic cell is clearly visible, and the lymph node structure is preserved both in
the cortex (violet-surrounded area) and in the medulla (4x magnication). (b) 10x magnication of the boxed area shown in (a).
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(“the chemical shift criterion”) on enhanced images was
considered a sign of benign normal nodes [31, 32]. Par-
ticularly, the benign nodes fell into the category of “sharply
delineated and intact chemical shift artefact,” whereas an
irregular or optically “interrupted” chemical shift artefact or
a pronounced enhancing rim encircling the entire node was
considered as a malignant criterion.
5. Conclusions
In conclusion, the results obtained showed a heterogeneous
pattern of enhancement in normal lymph nodes, in-
dependently of the contrast agent used. Semiautomatic
cluster analysis of signal intensity vs. time data showed the
existence of two clusters characterized by diﬀerent signal
intensity dynamics belonging to the inner and outer regions
of lymph nodes.
.is heterogeneous pattern might be peculiar of normal
lymph nodes and, if conﬁrmed on human lymph nodes,
should be deeply investigated to assess any alteration pos-
sibly induced by the metastatic transformation and, con-
sequently, its potential role for nodal staging.
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